NCIRD COVID-19 Project Plan.docx

Center for Surveillance, Epidemiology and Laboratory Services (CSELS)/Division of Laboratory Systems (DLS)

FY 2020 CIO PROJECT PLAN

CDC-RFA-OE15-15010501SUPP20: CDC/APHL Partnership: “Strengthening Public Health Laboratories”

GENERAL INFORMATION

CIO: National Center for Immunization and Respiratory Diseases (NCIRD) Office of the Director (OD)

CIO POC Name: Sandra Roush CIO POC E-Mail Address: swr1@cdc.gov CIO POC Phone Number: 404-639-8741

$_9,700,000____ (Whole #s Only)7

|_| Remainder of Current Budget Period Only |_| Remainder of Project Period (through June 30, 2020):

|X| Other: Please specify. (One Year ONLY)

PROPOSED PROJECT/ACTIVITY

|X| New Project/Activity?

Need Identified by: |_| Grantee |X| CIO

|_| Existing Project/Activity?

Projects/Activities currently identified in the published FOA reflected below. Select the project/activity that is most suitable.

Cross-Cutting Areas (Identify specific project/activity):

|_| Laboratory Strengthening and Leadership |X| Public Health Preparedness and Response |X| Public Laboratory Informatics |_| Global Health |X| Laboratory Systems and Standards |_| Workforce Development

Program Specific Areas (Identify specific project/activity):

|_| Newborn Screening and Genetics |_| Environmental Health |X| Infectious Diseases |_| Food Safety |X| Other. Specify: 2019 COVID-19 Response

The 2019 Coronavirus Disease (COVID-19) is an emerging, and rapidly evolving novel virus spreading from person-to-person in the United States. COVID-19 poses a significant public health risk because of its ability to cause serious illness and death. The federal government seeks to work closely with state, local, tribal, territorial (STLT) and public health partners for this public health response. To respond to this novel public health threat and protect the nation, CDC is providing funding to key national partners with current cooperative agreements to support accelerated state and local public health preparedness planning and operational support for the COVID-19 response. The goal of this funding is to ensure the optimal response to prevention, detection, monitoring and control of 2019 novel coronavirus (COVID-19) through the efforts of non-governmental organizations (NGOs). NGOs are uniquely positioned to strengthen response efforts, whether through mobilizing their own constituents or by providing technical assistance to public sector health departments. These organizations have contributed to the quality, efficiency and speed of the COVID-19 response, and are important collaborators with CDC and STLT partners. The funding is intended to support the following strategies, activities, and outcomes:

· Conduct preparedness assessments and facilitate evaluations of new technologies and methods, develop resources and provide technical assistance to state and local PHLs to ensure capability and capacity to respond to all public health threats

· Analyze biosafety and biosecurity guidelines and regulations and develop best practices and policies to enhance biosafety and biosecurity in PHLs

· Promote national, state and local PHL systems that collaborate with clinical laboratories

· Promote and support health systems-oriented laboratory informatics and information sharing practices, use of new data exchange technologies and standards-based interoperability

· Conduct regular assessments of laboratory capability and capacity including equipment availability, reagent shortages, assay implementation changes and other pressing issues

· Establish mechanisms that provide interim solutions to temporary supply chain challenges

· Work with CDC and a network of public health laboratories to conduct validation studies and adjust existing tests

· Conduct educational activities in person and online for public health laboratories as travel restrictions require. These will also encompass developing and sharing information on biosafety, including risk assessments, with public health and private clinical laboratories

· Maintain COVID-19 Taskforce to inform laboratory aspects of the response

· Work with public health laboratories to convene at least four forums, which engages private clinical laboratories including academic laboratories to discuss response needs

· Place two APHL Bioinformatics Fellows in relevant laboratories to address COVID-19 needs including direct device reporting and next generation sequencing

· Develop tools and resources to educate partners and the public on laboratory testing processes, test performance and the role of the public health laboratory system in emerging infectious disease response

· Provide technical assistance to public health laboratories to ensure continued availability of PHLIP data accommodating vocabulary and assay changes

· Establish systems for direct device reporting through AIMS to facilitate transfer of COVID-19 data from systems similar to Cepheid GeneExpert and bioMerieux BioFire

· Establish systems to aid public health laboratories in test ordering and reporting of test results

Mid-Term Outcomes |X| Promotes competent, collaborative, and practice ready PHL workforce |X| Improves laboratory methods, systems, and informatics capacity |X| Increases laboratory effectiveness in response to public health needs, including emergencies |X| Improves public health laboratory detection and response programs |X| Develops model policies and tools for quality and safe PHL practice |X| Assures CLIA standards and good laboratory practices are followed by PHLs and are promoted to clinical laboratories performing tests of public health importance |X| Other: Prepared netwok of public and private laboratories.

Long-Term Outcomes |X| Reduces incidence and prevalence of preventable diseases and public health threats |X| Reduces morbidity and mortality equitably delivered throughout the United States and the world |X| Protects the public from public health threats |X| Creates sustainable and resilient PHLs that effectively and efficiently adapt to evolving public health needs |X| Revises standards for the PHL system resulting in a more efficient, higher quality, and safe PHL system |_| Other ____________________________________________________________________________________

BUDGET INSTRUCTIONS

CIO CERTIFICATION

image1.png